Acadia Pharmaceuticals (ACAD) Debt Ratio (2010 - 2012)

Acadia Pharmaceuticals (ACAD) recorded quarterly Debt Ratio of 0.0 in Q1 2012, down 16.75% quarter-over-quarter from 0.0 in Q4 2011.

Acadia Pharmaceuticals (ACAD) Debt Ratio (2010 - 2012) Analysis & Trends

Acadia Pharmaceuticals' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q1 2012.

  • In Q1 2012, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2012 stood at 0.0 (changed N/A YoY), while the FY2011 annual figure was 0.0, down 50.95% from the prior year.
  • Debt Ratio was 0.0 for Q1 2012 at Acadia Pharmaceuticals, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.0 in Q4 2010 to a low of 0.0 in Q1 2012.
  • Historically, Debt Ratio has averaged 0.0 across 3 years, with a median of 0.0 in 2011.
  • Biggest YoY gain for Debt Ratio was 50.95% in 2011; the steepest drop was 50.95% in 2011.
  • A 3-year view of Debt Ratio shows it stood at 0.0 in 2010, then slumped by 50.95% to 0.0 in 2011, then decreased by 16.75% to 0.0 in 2012.
  • The last three Debt Ratio figures came in at 0.0 (Q1 2012), 0.0 (Q4 2011), and 0.0 (Q3 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Acadia Pharmaceuticals 3.68 Bn 2.83 Bn 243.27 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2012 0.00
Dec 31, 2011 0.00
Sep 30, 2011 0.00
Jun 30, 2011 0.00
Dec 31, 2010 0.00